Skip to content
Drug recall · FDA · Published June 28, 2019

Fresenius Kabi USA, LLC recalls Fluorouracil Injection, USP, 5 g / 100 mL (50 mg / mL), 100 mL fill in a 100 mL vial, Rx Only, Mfd. by: Fresenius Kabi,

Fresenius Kabi recalls Fluorouracil Injection vials with glass particulates that could cause serious injury during medical use. Affected lots include NDC 63323-117-61 and 63323-117-69.

🇺🇸 FDA recall #D-1489-2019DrugFresenius Kabi ›
Take action

Contact the company & request your remedy

Recalling firmFresenius Kabi USA, LLC2045 Cornell Ave, N/A · Melrose Park, IL 60160-1002
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Fresenius Kabi is recalling Fluorouracil Injection vials that may contain glass particles. This hazard could cause serious injury if the medication is administered improperly. Read more at govinfonow.com/recall/38488-fresenius-kabi-fluorouracil-injection-recall-glass-particulates-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38488-fresenius-kabi-fluorouracil-injection-recall-glass-particulates-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1489-2019

Cite this page

“Fresenius Kabi Fluorouracil Injection Recall: Glass Particulates Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38488-fresenius-kabi-fluorouracil-injection-recall-glass-particulates-risk. Based on FDA recall #D-1489-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1489-2019%22&limit=1).

Why it’s dangerous

Glass particles in the injection vials could become dislodged during administration, potentially causing tissue damage or serious injury to the patient. This risk is particularly concerning for chemotherapy treatments where precise delivery is critical.

Who’s affected

Patients receiving chemotherapy treatment with this specific Fluorouracil injection are affected. Healthcare providers using the product in clinical settings are at risk.

How to tell if you have this one

Check for vials labeled with NDC 63323-117-61 (Fresenius Kabi brand) or NDC 63323-117-69 (NOVAPLUS brand). The affected lots are 6120420 and 6120341.

  • Brand
    Fresenius Kabi
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Vial Label

    Look for the NDC codes 63323-117-61 or 63323-117-69 on the vial label.

  2. Contact Healthcare Provider

    If you have the affected vial, inform your healthcare provider immediately about the product lot number.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may contain glass particles that could cause serious injury during administration. Do not use the affected vials.

What should I do if I have the affected vial?

Contact your healthcare provider immediately and do not use the vial. They will advise on next steps.

How can I identify the affected lots?

Check the vial label for NDC 63323-117-61 (Fresenius Kabi brand) or NDC 63323-117-69 (NOVAPLUS brand) with lot numbers 6120420 or 6120341.

Take action

Contact Fresenius Kabi

We’ve drafted a message you can send Fresenius Kabi to request your refund or repair — edit it as you like.

Subject: Recall D-1489-2019 — Fresenius Kabi Fresenius Kabi

Hello,

I own a Fresenius Kabi that is covered by recall D-1489-2019 from Fresenius Kabi.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1489-2019 (June 28, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1489-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA